ProCE Banner Activity

Oral SERDs and Novel Endocrine Therapies: Reshaping the Treatment Landscape for ER+/HER2- Breast Cancer

Slideset

Download this slideset from a live symposium to learn the latest data on oral SERDs and other novel endocrine therapies that are changing the treatment landscape for patients with ER+/HER2- breast cancer.

Released: December 01, 2023

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca